Back to top

Image: Bigstock

New Strong Buy Stocks for December 4th

Read MoreHide Full Article

Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List today:

MDC Partners Inc. : This company that provides strategic consulting solutions has seen the Zacks Consensus Estimate for its current year earnings increasing 55.6% over the last 60 days.

MDC Partners Inc. Price and Consensus

 

MDC Partners Inc. Price and Consensus

MDC Partners Inc. price-consensus-chart | MDC Partners Inc. Quote

Alamo Group Inc. (ALG - Free Report) : This manufacturer of agricultural equipment and infrastructure maintenance equipment has seen the Zacks Consensus Estimate for its current year earnings increasing 7.4% over the last 60 days.

Alamo Group, Inc. Price and Consensus

 

Alamo Group, Inc. Price and Consensus

Alamo Group, Inc. price-consensus-chart | Alamo Group, Inc. Quote

Bazaarvoice, Inc. (BV - Free Report) : This company that provides marketing tools to retailer and brand clients has seen the Zacks Consensus Estimate for its current year earnings increasing 37.5% over the last 60 days.

Bazaarvoice, Inc. Price and Consensus

 

Bazaarvoice, Inc. Price and Consensus

Bazaarvoice, Inc. price-consensus-chart | Bazaarvoice, Inc. Quote

Coherent, Inc. (COHR - Free Report) : This provider of lasers and laser-based technology has seen the Zacks Consensus Estimate for its current year earnings increasing 4.8% over the last 60 days.

Coherent, Inc. Price and Consensus

 

Coherent, Inc. Price and Consensus

Coherent, Inc. price-consensus-chart | Coherent, Inc. Quote

CRA International, Inc. (CRAI - Free Report) : This consulting company has seen the Zacks Consensus Estimate for its current year earnings increasing 2.6% over the last 60 days.

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>